NewsLatest news from ARNS
ARNS 2020 Virtual Conference
As you know, in response to the global challenge, the decision was made to postpone the ARNS Annual Conference 2020 which was due to be held in Liverpool on 15th-16th May.
We are now delighted to announce that ARNS will be offering a virtual conference, taking place on Friday 14th August 2020.
By offering a virtual conference, ARNS can continue supporting our community to share the latest information, connect and access education during these challenging times.
Alongside the comprehensive programme, a platform for knowledge exchange, the 2020 conference is designed to enable attendees to interact and actively participate.
Registration is only £25 and will provide a year’s membership to ARNS.
To register click HERE
Late Breaking Abstracts
ARNS are delighted to re-open abstract submission for any late breaking abstracts. Closing date – Midnight, Monday 13th July
For this years conference we are calling for abstracts for thematic poster and spoken presentations. Awards will be given for the best in both categories. These may include reports of clinical audit, research, innovation in practice, or evaluation of clinical processes and systems. Previously published or presented work is also welcome. Further to this we will also welcome case studies and clinical reflections.
The abstracts will be judged on specific criteria by an independent panel. Authors of the three highest scoring abstracts will be invited to deliver a pre-recorded presentation and facilitate live Q&A, and will have an opportunity to publish in the Nursing Times. All authors of accepted abstracts will be required to submit an ePoster into the virtual poster room where questions can be put to authors via our on line chat option; therefore at least one of the authors must be registered at the conference.
For guidance and to submit your abstract, please click HERE
Further information, including a programme, will be available very soon.
We look forward to seeing you all in August.
We are aware that you are working under very difficult conditions at the moment with patients who may feel extremely anxious about COVID-19 and the potential impact it may have on them. This is not helped by some of the misinformation that is being spread across social media, making a complex situation even more challenging. In reality, the information we have about coronavirus is limited, and evidence is being gathered all the time in rapidly evolving circumstances about how it behaves.
We have trawled the internet for reliable sources of information and have added links to this statement so you can keep up to date as we become more knowledgeable about the virus and the illness. Here is a summary of what we have seen:
It is true that people who are old and/or have comorbidities are at increased risk of dying from COVID-19 yet despite this, most people with lung conditions experience mild symptoms only and will fully recover. Continuing with normal medication is key at present.
There are some problems with accessing supplies but these should be temporary and have in the main resulted from panic prescribing of large numbers of inhalers – a bit like the toilet roll/pasta situation. It is essential that clinicians stick to their normal prescribing practices to ensure that supplies meet demand. There is currently no issue with providing enough inhalers to meet the normal level of demand, even when inhalers are made and transported from abroad.
This is perhaps, the most controversial area, as many people will have been told to have a rescue pack ready for worsening symptoms, whereas others will have been told that oral steroids will make COVID-19 worse. ERS states that there is no evidence that prednisolone can make COVID-19 worse and the World Health Organization says that steroids should still be used for people with COPD who have a COVID-19 related flare up. BTS states that oral steroids should be used in acute asthma in the usual way and should not be withheld.
Current asthma treatment should be continued and no changes are necessary. No-one should need to step up treatment because of the current situation. ERS says that Anti-IL-5 should have no effect on the risk of getting COVID-19, and continuing on it could theoretically reduce the risk of an asthma attack if infected with the virus. Asthma UK has produced some detailed information for patients which can be found here: https://www.asthma.org.uk/advice/triggers/coronavirus-covid-19/. There is currently some debate about all patients who have been admitted in the past year needing to be shielded, as suggested in this document, particularly if their admission was many months ago and led to better asthma management and control. Each case should be assessed individually.
The recommendation is that current therapy should be continued and that antibiotics and oral steroids should be used in the same way that they normally would for exacerbations (see above). However, the advice on bronchiectasis management (below) points out that antibiotics will not work against viral infections. The NICE antimicrobial guidance on acute exacerbations of COPD recommends caution in prescribing antibiotics. It may be that sputum colour and amount should guide the use of antibiotic therapy, further details can be found here.
People with bronchiectasis should ensure that airway clearance techniques are practised regularly, and more often in the event of an infection with coronavirus. Paracetamol can help with fever, but antibiotics will not work against the virus.
Other lung conditions
The ERS ‘FAQ’ page is generally reassuring about the risks for people with lung conditions but for more information go to this page: https://www.europeanlung.org/en/QA-covid-19
Mental health can impact on respiratory conditions such as asthma and this link may be helpful: https://www.mentalhealth.org.uk/publications/looking-after-your-mental-health-during-coronavirus-outbreak
Gov.uk link for vulnerable people to register for assistance: https://www.gov.uk/coronavirus-extremely-vulnerable
In these unprecedented times respiratory nurses are finding themselves in the front line of the pandemic. Some may be asked to enhance skills, others to teach, return to practice, or work in unfamiliar environments, in addition to thinking about their own and their family’s health. This will be an unsettling and anxious time and we are suggesting that respiratory nurses keep an account of their experiences during the pandemic to facilitate reflection and provide important documentary evidence. In an effort to capture the ‘nursing voice’ and learn from our individual and collective experiences, you may be asked at a later date to submit your journal and participate in further research. This will be entirely voluntary with anonymity and confidentiality preserved. You can find out more here.
PCRS have now opened up their forum community to non members so a wider healthcare professional audience can follow and join the Covid 19 discussions.
ARNS 2020 Conference Postponement
Due to the global concern regarding COVID-19 (coronavirus) outbreak, ARNS has agreed to postpone the ARNS Annual Conference scheduled for 15th-16th May 2020 in Liverpool. This was a very difficult decision, however, there is no greater importance than the health and safety of our members.
We are sorry to disappoint those who are already registered to attend, but safety and wellbeing has to come first.
We are currently working with the venue to establish a revised date in the Autumn, and will be in touch as soon as these arrangements are in place. Registrations will be carried forward to the revised dates.
Our heartfelt wishes are with all those impacted across the world, and particularly to our members dealing with the increased and unchartered work and home pressures that we are all undertaking.
We will be contacting everyone as soon as we have the new arrangements in place.
The 2nd edition of the Managing Malnutrition in COPD guideline has been published today. The document also includes a pthway for the appropriate use of ONS to support community health professionals.
“ARNS is delighted to be involved with the development and update of these guidelines” says Joanne King, Consultant Respiratory Nurse and panel representative for the Association of Respiratory Nurse Specialists (ARNS). “The first edition of the guidelines and the complimentary patient leaflets have been taken up widely by respiratory nurses across the UK and I hope they will find the updates in the guidance of assistance. By engaging with the multi-professional team in identifying and treating malnutrition we can offer continuity of nutritional care for patients leading to better outcomes and quality of life for patients.”
Download Managing Malnutrition in COPD : Here